Position in IBRX
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$3,470,079
+$343,849 QoQ
Shares Held
396,354
-2.8% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#57
of 403 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Plancorp, LLC holds $5,642,142 across 6 Biotechnology names. IBRX ranks #1 (61.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IBRX |
ImmunityBio, Inc.
This page
|
396,354 | $3,470,079 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
11,128 | $882,339 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
907 | $565,550 | |
| 4 | EXEL |
Exelixis, Inc.
|
8,068 | $438,979 | |
| 5 | RXRX |
Recursion Pharmaceuticals, Inc.
|
69,500 | $255,065 | |
| 6 | GNLX |
GENELUX Corp
|
10,010 | $30,130 |
All Filings in IBRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,470,079 | 396,354 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $3,126,230 | 407,592 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $537,478 | 271,454 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $667,781 | 271,456 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $716,649 | 271,458 | Shares | Sole | 2025-07-16 | |
| No filing history on record for this holder in this stock. | ||||||